Zhai LR, Zhang XW, Yu T, De JZ, Huang DW, Jia Y, et al. Primary ovarian carcinoid: two cases report and review of the literature. Medicine (United States). 2020;99(40):E21109.
Malla M, Marahatta R, Shrestha A, Pudasaini S. Ovarian carcinoid: a rare experience. Nepal Med Coll J. 2019;21(4):327–30.
Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Pathol Patterns Rev. 2001;115(suppl_1):S94–112.
Davis KP, Hartmann LK, Keeney GL, Shapiro H. Primary ovarian carcinoid tumors. Gynecol Oncol. 1996;61:259–65.
Article PubMed CAS Google Scholar
Li S, Wang X, Sui X, Zhang X, Yin M, Yang J. Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid. BMC Cancer. 2022;22(1):1090.
Article PubMed PubMed Central Google Scholar
Turla A, Zamparini M, Milione M, Grisanti S, Amoroso V, Pedersini R, et al. Ovarian strumal carcinoid: case report, systematic literature review and pooled analysis. Front Endocrinol (Lausanne). 2022;21(13): 871210.
Antovska VS, Trajanova M, Krstevska I, Gosheva I, Chelebieva J, Prodanova I. Ovarian strumal carcinoid tumour: case report. Open Access Maced J Med Sci. 2018;6(3):540–3.
Article PubMed PubMed Central Google Scholar
Salhi H, Laamouri B, Boujelbène N, Hassouna JB, Dhiab T, Hechiche M, et al. Primary ovarian carcinoid tumor: a report of 4 cases. Int Surg J. 2017;4(8):2826.
Fox DJ, Khattar RS. Carcinoid heart disease: presentation, diagnosis, and management. Heart. 2004;90:1224–8.
Article PubMed PubMed Central Google Scholar
Preda VA, Chitoni M, Talbot D, Reed N, Grossman AB. Primary ovarian carcinoid: extensive clinical experience with an underrecognized uncommon entity. Int J Gynecol Cancer. 2018;28(3):466–71.
Ulbright TM, Roth LM, Ehrlich CE. Ovarian strumal carcinoid. An immunocytochemical and ultrastructural study of two cases. Am J Clin Pathol 1982;77(5):622–31.
Article PubMed CAS Google Scholar
Kimura N, Sasano N, Namiki T. Evidence of hybrid cell of thyroid follicular cell and carcinoid cell in strumal carcinoid. Int J Gynecol Pathol. 1986;5(3):269–77.
Article PubMed CAS Google Scholar
Robboy SJ, Scully RE, Carcinoid S, Simmons R, Civantos F, Beach M, et al. Strumal carcinoid of the ovary. Cancer. 1980;46:2019–34.
Article PubMed CAS Google Scholar
Leniček T, Tomas D, Soljačić-Vraneš H, Kraljević Z, Klarić P, Kos M, et al. Strumal carcinoid of the ovary: report of two cases. Acta Clin Croat. 2012;51(4):649–53.
Vilar E, Salazar R, Pérez-García J, Cortes J, Öberg K, Tabernero J. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer. 2007;14:221–32.
Article PubMed CAS Google Scholar
Kong S, Sun J, Sui X, Zhang S, Qi Y, Ma Y, et al. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study. Acta Obstet Gynecol Scand. 2023;102:935–41.
Article PubMed PubMed Central CAS Google Scholar
Kurabayashi T, Minamikawa T, Nishijima S, Tsuneki I, Tamura M, Yanase T, et al. Primary strumal carcinoid tumor of the ovary with multiple bone and breast metas- tases. J Obstet Gynaecol Res. 2010;36:567–71.
Sarıhan S. Combination of immunotherapy and radiotherapy. Uludağ Med J. 2020;46(2):225–33.
Herrera FG, Irving M, Kandalaft LE, Coukos G. Rational combinations of immunotherapy with radiotherapy in ovarian cancer. Lancet Oncol. 2019;20(8):e417–33.
Article PubMed CAS Google Scholar
Khalife M, Shahid K, Dabney RS, Phan AT. Stereotactic body radiation therapy and immunotherapy. Clin Adv Hematol Oncol. 2019;17(9):518–23.
Comments (0)